Get started
Author

Maider Garnica

Observed names: M Garnica, M. Garnica
Observed institutions: Universidad Pública de Navarra (UPNA), Complejo Hospitalario de Navarra, Navarre Institute of Health Research, Navarrabiomed, Centro de Investigación Médica Aplicada, Universidad de Navarra
ORCID: 0000-0002-1825-774X
Observed ORCID: 0000-0002-1825-774X
OpenAlex ID: A5007580383
Understanding LAG-3 Signaling
2021 · Luisa Chocarro, Ester Blanco, et al. · International Journal of Molecular Sciences · 216
PDF
Clinical landscape of LAG-3-targeted therapy
2022 · L. Chocarro, E. Blanco, et al. · Immuno-Oncology Technology · 99
PDF
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor
2022 · Luisa Chocarro, Ana Bocanegra, et al. · Cells · 70
PDF
Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer
2022 · H Arasanz, A Bocanegra, et al. · Cancers · 43
PDF
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells
2022 · Anna Aiello, Mattia Emanuela Ligotti, et al. · International Journal of Molecular Sciences · 35
PDF
Hyperprogressive Disease: Main Features and Key Controversies
2021 · Hugo Arasanz, Miren Zuazo, et al. · International Journal of Molecular Sciences · 31
PDF
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets
2024 · Luisa Chocarro, Ester Blanco, et al. · EMBO Molecular Medicine · 20
CAR-T Cells for the Treatment of Lung Cancer
2022 · Luisa Chocarro, Hugo Arasanz, et al. · Life · 19
PDF
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors
2023 · Ester Blanco, Luisa Chocarro, et al. · International Journal of Molecular Sciences · 18
PDF
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells
2022 · Maider Garnica, Anna Aiello, et al. · International Journal of Molecular Sciences · 18
PDF
Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer
2023 · Ana Bocanegra, Gonzalo Fernández‐Hinojal, et al. · EMBO Reports · 17
PDF
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy
2022 · David Escors, Ana Bocanegra, et al. · International Journal of Molecular Sciences · 17
PDF
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination
2022 · Miriam Echaide, Ibone Labiano, et al. · Cancers · 15
PDF
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies
2024 · Ester Blanco, Noelia Silva-Pilipich, et al. · British Journal of Cancer · 14
PDF
Cutting-Edge CAR Engineering: Beyond T Cells
2022 · Luisa Chocarro, Ester Blanco, et al. · Biomedicines · 11
PDF
A Proteomic Atlas of Lineage and Cancer-Polarized Expression Modules in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets
2021 · Ester Blanco, Maria Ibañez-Vea, et al. · Journal of Personalized Medicine · 8
PDF
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments
2025 · Rodrigo A. Redondo-Frutos, Pedro Justicia-Lirio, et al. · Human Gene Therapy · 6
55P Clinical landscape of LAG-3-targeted therapy
2021 · L. Chocarro, E. Blanco, et al. · Annals of Oncology · 2
PDF
Unique protein expression profiles discriminate ex vivo differentiated monocytic MDSCs from TAMs.
2022 · Ester Blanco, Luisa Chocarro, et al. · Proceedings of MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS · 1
PDF
Role of the next-generation immune checkpoint LAG-3 in response and resistance to cancer immunotherapy
2022 · Luisa Chocarro, Ester Blanco, et al. · Proceedings of MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS · 1
PDF
LAG-3 Role in Inflammatory Diseases
2022 · Luisa Chocarro, Ester Blanco, et al. · Proceedings of MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS · 1
PDF
LAG-3 Role in Cardiovascular Diseases
2022 · Luisa Chocarro, Ester Blanco, et al. · Proceedings of MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS · 1
PDF
LAG-3 Role in Neurological Diseases
2022 · Luisa Chocarro, Ester Blanco, et al. · Proceedings of MOL2NET'22, Conference on Molecular, Biomedical & Computational Sciences and Engineering, 8th ed. - MOL2NET: FROM MOLECULES TO NETWORKS · 1
PDF
LAG-3 Role in Infection
2021 · Luisa Chocarro, Ester Blanco, et al. · 1
Improving CRISPR-Cas9 Screens in CAR T Cells: A Refined Method for Library Preparation
2026 · Maider Garnica, Patxi San Martin-Uriz, et al. · Journal of Visualized Experiments
Works count: 34
Citation count: 665
H-index: 14
I10-index: 15
Year
Topic
Type